Lotte Bjerre Knudsen, Chief Scientific Adviser for Research at Danish pharma giant Novo Nordisk, speaks about GLP-1-based ...

Oxyntomodulin (OXM) is a peptide hormone released by intestinal L cells after food intake. It acts as a dual agonist of glucagon-like peptide 1 (GLP-1) and glucagon receptors, regulating appetite, ...

Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a ...

Dr. Alexander Lake, Gastroenterologist at AdventHealth, continues his conversation with Gayle Guyardo, the host of Bloom, and discusses the interconnectedness of three organs ...

A new implantable device developed by engineers at MIT can release glucagon without any external effort. The implant, which ...

Hormones can be helpful heroes, supporting the immune system and a healthy sleep-wake schedule. But they can also be culprits ...

Some weight loss drugs may cause hair loss. While it’s typically a temporary side effect, it can affect your confidence.

Learn how the benefits of GLP-1s may be outweighed by the risks.

The Semaglutide peptide has emerged as a compelling subject in biochemical and physiological research due to its potential ...

To date, almost 400 reports of acute pancreatitis have been received from people using GLP-1 drugs such as Mounjaro, Wegovy, ...

I was just a baby scientist when I discovered the hormone that made Ozempic possible. I had no idea how life-changing—and ...

The primary neoplasm was resected and shown to contain large amounts of glucagon, the hyperglycemic-glycogenolytic hormone of alpha cells. Hyperglucagonemia persisted in the patient, as did the ...